|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:101-107
© 2000 Mosby, Inc.
SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE |
From the Second Department of Surgerya and First Department of Internal Medicine,b Shinshu University School of Medicine, Matsumoto, Japan.
Supported in part by a grant from Japanese Ministry of Education, Science, Sports, and Culture (B-2, 09470246).
Address for reprints: Naohiko Koide, MD, Second Department of Surgery, Shinshu University School of Medicine, Asahi, 3-1-1, Matsumoto 390-8621, Japan (E-mail: surgery 2{at}hsp.md.shinshu-u.ac.jp).
Objective: To clarify the association between angiogenesis and the clinicopathologic features in cardiac myxoma, vascular endothelial growth factor expression in the myxoma was examined by using reverse transcriptase polymerase chain reaction and immunohistochemistry, and the microvessel density was determined by counting microvessels in the myxoma by using immunostaining for platelet endothelial cell adhesion molecule 1.
Methods: Seven fresh-frozen and 15 formalin-embedded tissues were analyzed by means of reverse transcriptase polymerase chain reaction and immunostaining for vascular endothelial growth factor, respectively. The microvessel density was measured in the 15 formalin-embedded tissues. Furthermore, immunostaining for proliferating cell nuclear antigen was performed, and the proliferating cell nuclear antigenlabeling index was calculated.
Results: All of the 7 analyzed myxomas were positive for vascular endothelial growth factor messenger RNA, as determined by means of reverse transcriptase polymerase chain reaction, whereas atrial septum and atrium tissues were negative. Positive immunohistochemical reaction for vascular endothelial growth factor was observed in the cells of all 15 myxomas. The size of myxomas with high vascular endothelial growth factor expression was smaller than that of myxomas with low vascular endothelial growth factor expression. The microvessel density in myxomas with high vascular endothelial growth factor expression was higher than that in myxomas with low vascular endothelial growth factor expression. There was an inverse correlation between the tumor size and the ratio of the microvessel density in the central part to the microvessel density in the peripheral part of myxomas. Furthermore, there was an inverse correlation between the proliferating cell nuclear antigenlabeling index and the tumor size, and the prolferating cell nuclear antigenlabeling index in myxomas with high vascular endothelial growth factor expression was higher than that in myxomas with low vascular endothelial growth factor expression.
Conclusions: Cardiac myxomas produce vascular endothelial growth factor, which probably induces angiogenesis for tumor growth.
This article has been cited by other articles:
![]() |
Y. Li, Z. Pan, Y. Ji, M. Sheppard, D. J. Jeffries, L. C. Archard, and H. Zhang Herpes Simplex Virus Type 1 Infection Associated with Atrial Myxoma Am. J. Pathol., December 1, 2003; 163(6): 2407 - 2412. [Abstract] [Full Text] |
||||
![]() |
K. R. Bennett, J.-W. Gu, T. H. Adair, and B. J. Heath Elevated plasma concentration of vascular endothelial growth factor in cardiac myxoma J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 193 - 194. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |